Nanoparticle-mediated Tolerance

Nanoparticle-Mediated Tolerance is a therapeutic strategy in immune tolerance induction that employs biocompatible nanoparticles to selectively deliver antigens or immunomodulatory agents to specific immune cells, thereby promoting antigen-specific immune unresponsiveness while minimizing systemic immunosuppression.

73

Publications

4.8K

Citations

480

Authors

177

Institutions

Publications per year

2017–2026

53

Authors

480

  1. SD
    Stephen D. Miller

    Northwestern University, United States

    10 publications · 940 citations

    10

    h-index

  2. LD
    Lonnie D. Shea

    Northwestern University, United States

    10 publications · 930 citations

    10

    h-index

  3. RM
    Ryan M. Pearson

    University of Maryland, Baltimore, United States

    5 publications · 377 citations

    5

    h-index

  4. DR
    Daniel R. Getts

    The University of Sydney, Australia

    4 publications · 644 citations

    4

    h-index

  5. KR
    Kevin R. Hughes

    University of Michigan, United States

    4 publications · 169 citations

    4

    h-index

1–5 of 480

Venues

  1. ACS Nano

    5 publications · 575 citations

    5

    h-index

  2. Biomaterials

    5 publications · 224 citations

    5

    h-index

  3. Nanomedicine

    4 publications · 168 citations

    4

    h-index

  4. Frontiers in Immunology

    3 publications · 144 citations

    3

    h-index

  5. Plant Stress

    2 publications · 102 citations

    2

    h-index

1–5